|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 73.70 USD | +0.61% |
|
-1.83% | +24.03% |
| 17/07 | Ingevity Receives BASt Approval For Evotherm P35 Warm-Mix Additive In Germany | CI |
| 25/06 | Ingevity Names Ryan Cotterman as Chief Accounting Officer | MT |
Company Valuation: Ingevity Corporation
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 2,817 | 2,632 | 1,711 | 1,481 | 2,128 | 2,547 | - | - |
| Change | - | -6.55% | -35.01% | -13.42% | 43.69% | 19.69% | - | - |
| Enterprise Value (EV) 1 | 3,791 | 4,028 | 3,082 | 2,814 | 3,259 | 3,587 | 3,484 | 3,430 |
| Change | - | 6.25% | -23.49% | -8.69% | 15.8% | 10.08% | -2.87% | -1.55% |
| P/E | 24.3x | 12.8x | -315x | -3.44x | -12.8x | 18.9x | 12.7x | 11.4x |
| PBR | 4.18x | 3.76x | - | 7.58x | 70.7x | - | - | - |
| PEG | - | 0.1x | 3x | -0x | 0.2x | -0x | 0.3x | 1x |
| Capitalization / Revenue | 2.02x | 1.58x | 1.01x | 1.05x | 1.65x | 2.3x | 2.25x | 2.21x |
| EV / Revenue | 2.72x | 2.41x | 1.82x | 2x | 2.53x | 3.23x | 3.08x | 2.97x |
| EV / EBITDA | 8.98x | 8.9x | 7.77x | 7.76x | 8.2x | 9.39x | 8.38x | 8.04x |
| EV / EBIT | 12.1x | 11.7x | 40.1x | 11.1x | 11.2x | 12.5x | 11x | 10.4x |
| EV / FCF | 20x | 23.6x | 32.3x | 55.2x | 11.9x | 13x | 14.3x | 13.3x |
| FCF Yield | 4.99% | 4.24% | 3.09% | 1.81% | 8.39% | 7.67% | 7% | 7.54% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 2.95 | 5.5 | -0.15 | -11.85 | -4.61 | 3.875 | 5.76 | 6.4 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 1,392 | 1,668 | 1,692 | 1,406 | 1,289 | 1,109 | 1,131 | 1,154 |
| EBITDA 1 | 422.2 | 452.6 | 396.8 | 362.7 | 397.5 | 382 | 415.8 | 426.6 |
| EBIT 1 | 312.3 | 343.8 | 76.9 | 254.4 | 291.1 | 287.5 | 316 | 330 |
| Net income 1 | 118.1 | 211.6 | -5.4 | -430.3 | -167.1 | 135.4 | 192.4 | 211 |
| Net Debt 1 | 974.6 | 1,396 | 1,371 | 1,333 | 1,130 | 1,040 | 937 | 883 |
| Reference price 2 | 71.70 | 70.44 | 47.22 | 40.75 | 59.18 | 73.26 | 73.26 | 73.26 |
| Nbr of stocks (in thousands) | 39,286 | 37,372 | 36,231 | 36,349 | 35,964 | 34,772 | - | - |
| Announcement Date | 23/2/22 | 27/2/23 | 21/2/24 | 18/2/25 | 25/2/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 18.91x | 3.23x | 9.39x | - | 2.55B | |
| 21.81x | 4.02x | 11.22x | 1.85% | 76.14B | |
| 14.33x | 0.91x | 7.75x | 4.71% | 47.62B | |
| 59.7x | 9.19x | 40.94x | 0.95% | 16.6B | |
| 15.25x | 0.97x | 7.15x | 2.44% | 15.18B | |
| 14.1x | 0.77x | 5.33x | 2.69% | 9.87B | |
| 16.59x | 0.71x | 8.04x | 3.11% | 9.71B | |
| 30.51x | 1.57x | 8.37x | 2.28% | 8.25B | |
| 32.89x | 4.52x | 19.26x | 0.35% | 8.19B | |
| 5.7x | 0.72x | 3.4x | -.--% | 7.66B | |
| Average | 22.98x | 2.66x | 12.08x | 2.04% | 20.18B | |
| Weighted average by Cap. | 22.20x | 2.95x | 11.99x | 2.49% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- NGVT Stock
- Valuation Ingevity Corporation
Select your edition
All financial news and data tailored to specific country editions
